The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer

Author(s): Seong Lin Teoh, Srijit Das*.

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 12 , 2017

Become EABM
Become Reviewer

Abstract:

The incidence and mortality due to breast cancer is increasing worldwide. There is a constant quest to know the underlying molecular biology of breast cancer in order to arrive at diagnosis and plan better treatment options. MicroRNAs (miRNAs) are small non-coding and single stranded RNAs which influence the gene expression and physiological condition in any tumor. The miRNAs may act on different pathways in various cancers. Recently, there are research reports on various miRNAs being linked to breast cancers. The important miRNAs associated with breast cancers include miR-21, miR-155, miR-27a, miR-205, miR-145 and miR-320a. In the present review we discuss the role of miRNAs in breast cancer, its importance as diagnostic markers, prognosis and metastasis markers. We also highlight the role of miRNAs with regard to resistance to few anticancerous drugs such as Tamoxifen and Trastuzumab. The role of miRNA in resistance to treatment is one of the core issues discussed in the present review. Much information on the miRNA roles is available particularly in the neoadjuvant chemotherapy setting, because this protocol allows the rapid association of miRNA expression with the treatment response. This review opens the door for designing better therapeutic options in drug resistance cases in breast cancer.

Keywords: miRNAs, expression, breast cancer, marker, treatment, resistance.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 23
ISSUE: 12
Year: 2017
Page: [1845 - 1859]
Pages: 15
DOI: 10.2174/1381612822666161027120043
Price: $58

Article Metrics

PDF: 45
HTML: 9
EPUB: 2